HomeIndustriesBiotechnology

Biotechnology

Orna Therapeutics Raises $221 Million Series B Financing to Advance Circular RNA Platform

Orna Therapeutics, a biotechnology company pioneering a new class of fully engineered circular RNA therapies (oRNA), announced the initial closing of its $221 million...

Kronos Bio and Invivoscribe Partner on Companion Diagnostic

Kronos Bio, Inc., a company dedicated to transforming the lives of those affected by cancer, and Invivoscribe, a global provider of diagnostic kits and...

ICL and Lavie Bio Enter Strategic Collaboration to Develop Novel Bio-Stimulant Products

ICL, a leading global specialty minerals company, and Evogene Ltd., a leading computational biology company focused on revolutionizing product discovery and development in multiple...

3DBio Therapeutics and Microtia-Congenital Conduct Human Ear Reconstruction

3DBio Therapeutics (3DBio), a clinical-stage regenerative medicine company, and the Microtia-Congenital Ear Deformity Institute announced they have conducted a human ear reconstruction using the...

Pneumagen Announces First Patient Dosed in Phase 2 Proof of Concept

Pneumagen, a clinical stage biotech company developing Neumifil, an intranasal, broad-spectrum antiviral treatment to prevent or, if infected reduce and manage viral respiratory tract...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics